Contact
Please use this form to send email to PR contact of this press release:
FDA Grants Rare Pediatric Disease Designation (RPDD) to Volasertib for Rhabdomyosarcoma
TO:
Berta Marti Fuster
Oncoheroes Biosciences Inc
+1 857-999-1378